NanJing Pharmaceutical Co Ltd (600713) — Cash Flow-to-Debt Ratio
NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-942.93 Million could theoretically repay 0% of its total liabilities (CN¥26.09 Billion) in one year. Explore long-term investment intensity of NanJing Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NanJing Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for NanJing Pharmaceutical Co Ltd across 27 annual periods. Also explore NanJing Pharmaceutical Co Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NanJing Pharmaceutical Co Ltd (1998–2024)
Year-by-year debt coverage analysis for NanJing Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600713 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥2.14 Billion | CN¥22.89 Billion | ▲ +3.6% |
| 2023 | 0.09x | CN¥1.91 Billion | CN¥21.16 Billion | ▲ +429.6% |
| 2022 | -0.03x | CN¥-682.31 Million | CN¥24.96 Billion | ▼ -181.2% |
| 2021 | 0.03x | CN¥695.33 Million | CN¥20.65 Billion | ▲ +154.3% |
| 2020 | -0.06x | CN¥-1.15 Billion | CN¥18.59 Billion | ▼ -207.7% |
| 2019 | 0.06x | CN¥1.00 Billion | CN¥17.45 Billion | ▲ +342.3% |
| 2018 | -0.02x | CN¥-366.90 Million | CN¥15.45 Billion | ▼ -194.6% |
| 2017 | 0.03x | CN¥319.99 Million | CN¥12.74 Billion | ▲ +213.6% |
| 2016 | -0.02x | CN¥-240.88 Million | CN¥10.89 Billion | ▲ +28.4% |
| 2015 | -0.03x | CN¥-306.08 Million | CN¥9.91 Billion | ▲ +19.1% |
| 2014 | -0.04x | CN¥-341.01 Million | CN¥8.92 Billion | ▲ +9.8% |
| 2013 | -0.04x | CN¥-354.27 Million | CN¥8.36 Billion | ▼ -299.4% |
| 2012 | 0.02x | CN¥168.17 Million | CN¥7.91 Billion | ▲ +123.5% |
| 2011 | -0.09x | CN¥-692.53 Million | CN¥7.67 Billion | ▼ -639.4% |
| 2010 | 0.02x | CN¥119.08 Million | CN¥7.11 Billion | ▲ +378.2% |
| 2009 | 0.00x | CN¥20.22 Million | CN¥5.77 Billion | ▲ +258.8% |
| 2008 | 0.00x | CN¥4.33 Million | CN¥4.43 Billion | ▼ -94.8% |
| 2007 | 0.02x | CN¥81.08 Million | CN¥4.30 Billion | ▼ -64.4% |
| 2006 | 0.05x | CN¥161.31 Million | CN¥3.04 Billion | ▼ -14.1% |
| 2005 | 0.06x | CN¥165.57 Million | CN¥2.68 Billion | ▲ +856.7% |
| 2004 | 0.01x | CN¥16.26 Million | CN¥2.52 Billion | ▼ -32.4% |
| 2003 | 0.01x | CN¥19.27 Million | CN¥2.02 Billion | ▼ -81.8% |
| 2002 | 0.05x | CN¥68.75 Million | CN¥1.31 Billion | ▲ +970.8% |
| 2001 | -0.01x | CN¥-4.20 Million | CN¥697.93 Million | ▼ -105.1% |
| 2000 | 0.12x | CN¥87.68 Million | CN¥742.31 Million | ▲ +17.1% |
| 1999 | 0.10x | CN¥50.58 Million | CN¥501.56 Million | ▼ -42.7% |
| 1998 | 0.18x | CN¥77.45 Million | CN¥440.31 Million | — |